We hypothesize that propofol combined with ketamine has a optimal physician’s satisfaction, patient’s satisfaction and hemodynamic stability, in comparison with propofol combined with either alfentanil or remifentanil.
ID
Bron
Verkorte titel
Aandoening
We evaluate the role of injection of ketamine as an analgesic component of anesthesia in comparison with the other analgesics (opioids) in procedural sedation and analgesia therapy (PSA) because of the increasing importance of physician’s satisfaction during performing procedures and patient’s comfort.
Ondersteuning
Michelangelolaan 2
5623 EJ Eindhoven
The Netherlands
040-2399111
www.cze.nl
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The primary endpoint of this study is physician’s satisfaction with the applied sedation technique, measured on a Likert five-item scoring system.
Doel van het onderzoek
We hypothesize that propofol combined with ketamine has a optimal physician’s satisfaction, patient’s satisfaction and hemodynamic stability, in comparison with propofol combined with either alfentanil or remifentanil.
Onderzoeksopzet
T = 0: before induction
T = 1: start of PSA
T = 2: end of induction PSA
T = 3: start of procedure by physician
T = 4: sedation parameters (every 15 minutes)
T = 5: end of procedure
T = 6: end of PSA
T = 7: start recovery
T = 8: end of recovery / discharge to the ward
Onderzoeksproduct en/of interventie
For sedation, a propofol perfusor will be started combined with ketamine, even administered by perfusor. During the procedure, doses of propofol and ketamine will be fitted to the clinical situation, to reach and maintain an OAA/S score of at least 3 and to consider cardio-respiratory stability. After finishing the procedure by the physician, administration of perfusor medication will be ended.
Algemeen / deelnemers
Wetenschappers
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Inclusion criteria are requirement for PSA, patients aged 18 years or older and with an American Society of Anesthesiology class 1 to 3. Patients will be included in this study after given written informed consent before the treatment starts.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Patients will be excluded form the study if they are unable to give informed consent, are pregnant, has a known allergy to either study medication, are receiving treatment for neuromuscular or psychiatric disease or has a physical or communicational disorder.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL4515 |
| NTR-old | NTR4633 |
| Ander register | : |